Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Pincus

Showing results (41-50 of 202) with videos related to

Pageof 21
Sort By:
BMJ Open|October 25, 2011
Poor physical function, pain and limited exercise: risk factors for premature mortality in the range of smoking or hypertension, identified on a simple patient self-report questionnaire for usual careTuulikki Sokka, Theodore Pincus
Lancet (London, England)|August 12, 2009
Rheumatoid arthritis: strategy more important than agentTuulikki Sokka, Theodore Pincus
The Journal of Rheumatology|May 5, 2009
Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United StatesTuulikki Sokka, Theodore Pincus
The Journal of Rheumatology|December 5, 2002
Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patientsTuulikki Sokka, Theodore Pincus
Bulletin of the NYU Hospital for Joint Diseases|August 16, 2012
An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician reportTheodore Pincus, Isabel Castrejón
The Journal of Rheumatology|April 1, 2005
Patient questionnaires for clinical research and improved standard patient care: is it better to have 80% of the information in 100% of patients or 100% of the information in 5% of patients?Theodore Pincus, Frederick Wolfe
Rheumatic Diseases Clinics of North America|October 19, 2004
Clinical trials in rheumatic diseases: designs and limitationsTheodore Pincus, Tuulikki Sokka
Bulletin of the NYU Hospital for Joint Diseases|December 25, 2012
Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis--documentation using a patient self-report Multidimensional Health Assessment Questionnaire (MDHAQ)Theodore Pincus, Isabel Castrejón
Bulletin of the Hospital for Joint Disease (2013)|November 14, 2013
Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-targetTheodore Pincus, Isabel Castrejón
Rheumatic Diseases Clinics of North America|April 7, 2007
Quantitative measures to assess patients with rheumatic diseases: 2006 updateTheodore Pincus, Tuulikki Sokka
Pageof 21

Showing results (41-50 of 202) with videos related to

Sort By:
Pageof 21
BMJ Open|October 25, 2011
Poor physical function, pain and limited exercise: risk factors for premature mortality in the range of smoking or hypertension, identified on a simple patient self-report questionnaire for usual careTuulikki Sokka, Theodore Pincus
Lancet (London, England)|August 12, 2009
Rheumatoid arthritis: strategy more important than agentTuulikki Sokka, Theodore Pincus
The Journal of Rheumatology|May 5, 2009
Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United StatesTuulikki Sokka, Theodore Pincus
The Journal of Rheumatology|December 5, 2002
Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patientsTuulikki Sokka, Theodore Pincus
Bulletin of the NYU Hospital for Joint Diseases|August 16, 2012
An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician reportTheodore Pincus, Isabel Castrejón
The Journal of Rheumatology|April 1, 2005
Patient questionnaires for clinical research and improved standard patient care: is it better to have 80% of the information in 100% of patients or 100% of the information in 5% of patients?Theodore Pincus, Frederick Wolfe
Rheumatic Diseases Clinics of North America|October 19, 2004
Clinical trials in rheumatic diseases: designs and limitationsTheodore Pincus, Tuulikki Sokka
Bulletin of the NYU Hospital for Joint Diseases|December 25, 2012
Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis--documentation using a patient self-report Multidimensional Health Assessment Questionnaire (MDHAQ)Theodore Pincus, Isabel Castrejón
Bulletin of the Hospital for Joint Disease (2013)|November 14, 2013
Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-targetTheodore Pincus, Isabel Castrejón
Rheumatic Diseases Clinics of North America|April 7, 2007
Quantitative measures to assess patients with rheumatic diseases: 2006 updateTheodore Pincus, Tuulikki Sokka
Pageof 21